IP Verse

Bulle Dr., Jan opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Bulle Dr., Jan

Patent Number:
EP3626270
Title:
New Use
Applicant:
NOVARTIS AG
Opposition Date:
Jul 10, 2024
Patent Number:
EP3532481
Title:
Method For Producing Allulose Crystals
Applicant:
TATE & LYLE INGREDIENTS AMERICAS LLC
Opposition Date:
Mar 14, 2024
Patent Number:
EP3810201
Title:
Gip/Glp1 Agonist Compositions
Applicant:
ELI LILLY AND COMPANY
Opposition Date:
Mar 7, 2024
Patent Number:
EP3294283
Title:
Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure
Applicant:
NOVARTIS AG
Opposition Date:
Dec 8, 2023
Patent Number:
EP3663375
Title:
Structural Adhesive Compositions
Applicant:
PPG INDUSTRIES OHIO, INC.
Opposition Date:
Oct 18, 2023
Patent Number:
EP3067043
Title:
Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) Inhibitor
Applicant:
NOVARTIS AG
Opposition Date:
Aug 28, 2023
Patent Number:
EP3261455
Title:
Allulose Syrups
Applicant:
TATE & LYLE INGREDIENTS AMERICAS LLC
Opposition Date:
Oct 26, 2022
Patent Number:
EP3725778
Title:
Formulations Of Enzalutamide
Applicant:
ASTELLAS PHARMA INC.
Opposition Date:
May 18, 2022
Patent Number:
EP3102186
Title:
Donepezil Compositions And Method Of Treating Alzheimer'S Disease
Applicant:
DEDHIYA, MAHENDRA, G.
Opposition Date:
Oct 27, 2021
Patent Number:
EP3102208
Title:
Crystalline Polymorphs Of The Free Base Of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Applicant:
GLOBAL BLOOD THERAPEUTICS, INC.
Opposition Date:
Oct 13, 2021

Competitors of Bulle Dr., Jan

NOVARTIS AG

ALFRED E. TIEFENBACHER (GMBH & CO. KG)

ASTELLAS PHARMA INC.

Want to track Bulle Dr., Jan?

Feel free to send us a message here and we will get back to you